Int J Cancer

• 

  Publication Venue For

  • Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival..  149:1302-1312. 2021
  • Novel functional variants in the Notch pathway and survival of Chinese colorectal cancer..  149:84-96. 2021
  • First- and second-degree family history of ovarian and breast cancer in relation to risk of invasive ovarian cancer in African American and white women..  148:2964-2973. 2021
  • Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population-based cohort studies and two-sample Mendelian randomization analyses..  148:1338-1350. 2021
  • Menopausal hormone therapy use and long-term all-cause and cause-specific mortality in the Long Island Breast Cancer Study Project..  147:3404-3415. 2020
  • Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee..  147:3168-3176. 2020
  • Potentially functional genetic variants in PLIN2, SULT2A1 and UGT1A9 genes of the ketone pathway and survival of nonsmall cell lung cancer..  147:1559-1570. 2020
  • The U-shaped association between body mass index and gastric cancer risk in the Helicobacter pylori Biomarker Cohort Consortium: A nested case-control study from eight East Asian cohort studies..  147:777-784. 2020
  • Novel genetic variants in KIF16B and NEDD4L in the endosome-related genes are associated with nonsmall cell lung cancer survival..  147:392-403. 2020
  • Identification of novel epithelial ovarian cancer loci in women of African ancestry..  146:2987-2998. 2020
  • Cancer incidence in relation to body fatness among 0.5 million men and women: Findings from the China Kadoorie Biobank..  146:987-998. 2020
  • Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics..  146:739-748. 2020
  • Genetic variants in ELOVL2 and HSD17B12 predict melanoma-specific survival..  145:2619-2628. 2019
  • Genetic variants of genes in the NER pathway associated with risk of breast cancer: A large-scale analysis of 14 published GWAS datasets in the DRIVE study..  145:1270-1279. 2019
  • Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients..  145:621-631. 2019
  • Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States..  145:143-153. 2019
  • Relationship of DNA methylation to mutational changes and transcriptional organization in fusion-positive and fusion-negative rhabdomyosarcoma..  144:2707-2717. 2019
  • A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variants..  144:2192-2205. 2019
  • Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival..  144:1867-1876. 2019
  • Somatostatin receptor 2 signaling promotes growth and tumor survival in small-cell lung cancer..  144:1104-1114. 2019
  • Functional variant of MTOR rs2536 and survival of Chinese gastric cancer patients..  144:251-262. 2019
  • BMI1 enhancer polymorphism underlies chromosome 10p12.31 association with childhood acute lymphoblastic leukemia..  143:2647-2658. 2018
  • Profiles of brain metastases: Prioritization of therapeutic targets..  143:3019-3026. 2018
  • Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age..  143:2359-2366. 2018
  • Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer..  143:2400-2408. 2018
  • Parabacteroides distasonis attenuates toll-like receptor 4 signaling and Akt activation and blocks colon tumor formation in high-fat diet-fed azoxymethane-treated mice..  143:1797-1805. 2018
  • A TGF-β1 genetic variant at the miRNA187 binding site significantly modifies risk of HPV16-associated oropharyngeal cancer..  143:1327-1334. 2018
  • Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells..  143:921-930. 2018
  • DNA methylation of imprinted gene control regions in the regression of low-grade cervical lesions..  143:552-560. 2018
  • Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival..  142:2303-2312. 2018
  • Genetic variants in the platelet-derived growth factor subunit B gene associated with pancreatic cancer risk..  142:1322-1331. 2018
  • An ERCC4 regulatory variant predicts grade-3 or -4 toxicities in patients with advanced non-small cell lung cancer treated by platinum-based therapy..  142:1218-1229. 2018
  • Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association Consortium..  142:460-469. 2018
  • Meta-analysis of the association between dietary inflammatory index (DII) and cancer outcomes..  141:2215-2227. 2017
  • Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx..  141:1355-1364. 2017
  • A PGC1β genetic variant associated with nevus count and melanoma mortality..  141:1066-1067. 2017
  • Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer..  141:731-743. 2017
  • Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival..  141:721-730. 2017
  • Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies..  140:2422-2435. 2017
  • BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer..  140:2051-2059. 2017
  • Genetic variants in the integrin signaling pathway genes predict cutaneous melanoma survival..  140:1270-1279. 2017
  • Genetic variants of JNK and p38α pathways and risk of non-small cell lung cancer in an Eastern Chinese population..  140:807-817. 2017
  • Lifecourse socioeconomic status and cancer-related risk factors: Analysis of the WHO study on global ageing and adult health (SAGE)..  140:777-787. 2017
  • Dietary inflammatory index and risk of epithelial ovarian cancer in African American women..  140:535-543. 2017
  • Fruit and vegetable consumption, Helicobacter pylori antibodies, and gastric cancer risk: A pooled analysis of prospective studies in China, Japan, and Korea..  140:591-599. 2017
  • A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer..  139:2646-2654. 2016
  • Genetic variants in the PIWI-piRNA pathway gene DCP1A predict melanoma disease-specific survival..  139:2730-2737. 2016
  • Telomere structure and maintenance gene variants and risk of five cancer types..  139:2655-2670. 2016
  • A prospective study of dietary patterns and cancer mortality among Blacks and Whites in the REGARDS cohort..  139:2221-2231. 2016
  • Early onset pancreatic malignancies: Clinical characteristics and survival associations..  139:2169-2177. 2016
  • A comprehensive genome-wide analysis of melanoma Breslow thickness identifies interaction between CDC42 and SCIN genetic variants..  139:2012-2020. 2016
  • Obesity, weight gain, and ovarian cancer risk in African American women..  139:593-600. 2016
  • Genetic variants in ABCG1 are associated with survival of nonsmall-cell lung cancer patients..  138:2592-2601. 2016
  • Screening for familial and hereditary prostate cancer..  138:2579-2591. 2016
  • CD90(+) stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer..  138:1971-1981. 2016
  • A quantitative microscopic approach to predict local recurrence based on in vivo intraoperative imaging of sarcoma tumor margins..  137:2403-2412. 2015
  • Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy..  137:2454-2461. 2015
  • Integrated pathway and epistasis analysis reveals interactive effect of genetic variants at TERF1 and AFAP1L2 loci on melanoma risk..  137:1901-1909. 2015
  • Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma..  137:1679-1690. 2015
  • Genetic variants in Hippo pathway genes YAP1, TEAD1 and TEAD4 are associated with melanoma-specific survival..  137:638-645. 2015
  • A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery..  136:1976-1984. 2015
  • The relationship between blood IL-12p40 level and melanoma progression..  136:1874-1880. 2015
  • Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries..  136:1125-1139. 2015
  • Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya..  136:392-398. 2015
  • TNF-α promoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx..  135:1615-1624. 2014
  • Epigenetic determinants of ovarian clear cell carcinoma biology..  135:585-597. 2014
  • Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy..  134:1907-1915. 2014
  • Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya..  134:740-745. 2014
  • Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers..  133:2234-2244. 2013
  • Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis..  133:1765-1775. 2013
  • Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx..  133:695-704. 2013
  • Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors..  132:2339-2348. 2013
  • Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors..  132:795-806. 2013
  • BMP-2 inhibits tumor growth of human renal cell carcinoma and induces bone formation..  131:1941-1950. 2012
  • Combined p53-related genetic variants together with HPV infection increase oral cancer risk..  131:E251-E258. 2012
  • Increase in circulating levels of IGF-1 and IGF-1/IGFBP-3 molar ratio over a decade is associated with colorectal adenomatous polyps..  131:512-517. 2012
  • The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer..  130:20-28. 2012
  • Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls..  129:1932-1939. 2011
  • Affinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas..  129:111-121. 2011
  • Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer..  128:2063-2074. 2011
  • Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients..  128:492-499. 2011
  • Allergies, obesity, other risk factors and survival from pancreatic cancer..  127:2412-2419. 2010
  • Recombinant single-chain variable fragment antibodies against extracellular epitopes of human multidrug resistance protein MRP3 for targeting malignant gliomas..  127:598-611. 2010
  • IDH1 and IDH2 hotspot mutations are not found in canine glioma..  127:245-246. 2010
  • Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo..  126:2893-2903. 2010
  • Targeting slow-proliferating ovarian cancer cells..  126:2448-2456. 2010
  • Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer..  126:1378-1389. 2010
  • Chronic cigarette smoke extract treatment selects for apoptotic dysfunction and mitochondrial mutations in minimally transformed oral keratinocytes..  126:19-27. 2010
  • IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas..  125:2673-2678. 2009
  • p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck..  125:2660-2665. 2009
  • IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era..  125:680-687. 2009
  • XRCC3 haplotypes and risk of gliomas in a Chinese population: a hospital-based case-control study..  124:2948-2953. 2009
  • Estimation of the effects of smoking and DNA repair capacity on coefficients of a carcinogenesis model for lung cancer..  124:2152-2158. 2009
  • Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population..  124:2172-2178. 2009
  • Re: KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancer (Int J Cancer 123: 2239-2246, 2008)..  124:2243-2244. 2009
  • DNA repair phenotype and cancer susceptibility--a mini review..  124:999-1007. 2009
  • Family history of cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium..  124:394-401. 2009
  • Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study..  123:1883-1891. 2008
  • Rationale for folate receptor alpha targeted therapy in "high risk" endometrial carcinomas..  123:1699-1703. 2008
  • Consortium analysis of 7 candidate SNPs for ovarian cancer..  123:380-388. 2008
  • Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: a case-control study..  122:2077-2084. 2008
  • In vitro benzo[a]pyrene diol epoxide-induced DNA damage and chromosomal aberrations in primary lymphocytes, smoking, and risk of squamous cell carcinoma of the head and neck..  121:2735-2740. 2007
  • Relationship between tumor response at therapy completion and prognosis in patients with Group III rhabdomyosarcoma: A report from the Children's Oncology Group. 2020